[New management strategies for hepatitis B].
Castelneau
Corinne
C
Service d'Hépatologie, INSERM U-481 et Centre de Recherche Claude Bernard sur les Hépatites Virales, Hôpital Beaujon, Clichy, France.
Boyer
Nathalie
N
Marcellin
Patrick
P
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D001086:Arabinofuranosyluracil / Q000031:analogs & derivatives / Q000627:therapeutic use; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000068679:Emtricitabine; D006147:Guanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006509:Hepatitis B / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D063065:Organophosphonates
D000998:Antiviral Agents; D063065:Organophosphonates; D003841:Deoxycytidine; D019259:Lamivudine; D001086:Arabinofuranosyluracil; C413685:entecavir; D006147:Guanine; C053001:adefovir; D000068679:Emtricitabine; C034935:clevudine; D000225:Adenine
Nouveautés thérapeutiques dans la prise en charge de l'hépatite B.